The Role of Medical Affairs in Lifecycle Management
The objective of this article is to discuss the paradigm shift in how companies plan for and deliver on the “long tail” of a drug’s impact even after Loss of Exclusivity (LoE) – a process known as lifecycle management (LCM).
What a Nurse and Patient Advocate Wants Medical Affairs to Know About Engaging Patients
Getting the most impact from a publication requires being able to define who the audience is and how to reach them, across both journals and online channels, especially in complex/niche cases. In this podcast, we discuss the benefits of taking an analytical approach.
Sharpen Communication Strategies at Speed: Can We Unlock the New Insights From “Alternative Metrics”?
Digital Science held a roundtable discussion with Medical Affairs leaders in Madrid in May 2024 on the topic of scientific communications strategies assessment and their success measurements for multiple stakeholders.
The Discoverability Dilemma: Navigating the Maze of Digital Content in Healthcare
The MAPS Puerto Rico Roundtable hosted by Real Chemistry in March 2024 discussed the integration of digital platforms, AI, and personalized content to enhance engagement with healthcare providers (HCPs). The panel emphasized the shift towards real-time, tailored information delivery and the importance of leveraging insights from both traditional and digital sources to support effective engagement strategies while ensuring compliance.
Measure, Master, Move: An Ecosystem Approach to Engaging KOLs Beyond the Clinic
Drawing on insights from a roundtable of industry leaders convened by Klick at the recent MAPS conference, let’s look at how viewing the KOL holistically can lead to new avenues of engagement and more multifaceted relationships.
Bridging the gap: How medical affairs is reshaping the future of clinical and commercial success
Addressing the critical importance of integrating robust scientific understanding into the commercial journey, pinpointing the need for medical affairs to take the helm in defining and communicating the commercial value of healthcare innovations.
Generating better outcomes for patients through strategic planning
From the choice of where to publish to the assessment of impact, every decision holds weight in medical research publication. And yet, the metrics that have been traditionally used to guide these decisions offer only a partial view. The result: a hit-or-miss situation when it comes to reaching the target audience—healthcare professionals (HCPs) and patients. Can a data-driven approach that incorporates both traditional and the newer alternative metrics hold the key to improved publication planning, impact and thereby better patient outcomes?
Modernizing Scientific Storytelling for Deeper Field Medical Engagement
In this podcast, we ask what is the ONE thing a company must implement in their transformation from the 40-slide deck to modern scientific storytelling.
A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders
In this podcast, we speak with Jill Donahue, author of the recently published (free!) book, “A Dose of Inspiration: 100 Purpose Stories from Pharma Leaders” about the individual and organizational benefits of discovering your purpose as an employee in the Life Sciences industry.